|
SoCalBio
Networking Forum
Personalized Medicine
Are We There Yet?
March
27,
2008
4:00 – 7:00 pm
UCLA Faculty Center
(Westwood, CA)
http://facultycenter.ucla.edu/
RSVP: https://www.123signup.com/register?id=ttrmq
Admission: SoCalBio
Member= $40 Non-Member= $75
Academic/Gov./Nonprofit= $40
Personalized medicine is the
practice of tailoring treatment to patients and their diseased cells
based on genetic/genomic knowledge and health information technology. It
is a therapeutic modality fueled by the genetic data and diagnostic
tools that emerged following the decoding of the human genome about ten
years ago. Personalized medicine represents a paradigm shift in health
care requiring a whole new approach to science, but progress in making
it a reality has been slow. Although many biotech firms and
institutional researchers are rallying around personalized medicine, the
timeline to new therapies is still being recalibrated. Join us to learn
from local companies about the emergence of consumer genomics and the prospects of personalized
medicine.
Speakers
-
Andy Goren,
CEO, HairDx (Irvine)
-
Walter
Narajowski, President & CEO, Pathway Diagnostics
(Malibu)
-
Peggy Pence,
Ph.D., President & CEO, Symbion Research (Agoura Hills)
-
Robert
Terbrueggen, Ph.D., President & CEO, DxTerity
Diagnostics (Rancho Dominguez)
|
